Cargando…

Overcoming intratumoural heterogeneity for reproducible molecular risk stratification: a case study in advanced kidney cancer

BACKGROUND: Metastatic clear cell renal cell cancer (mccRCC) portends a poor prognosis and urgently requires better clinical tools for prognostication as well as for prediction of response to treatment. Considerable investment in molecular risk stratification has sought to overcome the performance c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lubbock, Alexander L. R., Stewart, Grant D., O’Mahony, Fiach C., Laird, Alexander, Mullen, Peter, O’Donnell, Marie, Powles, Thomas, Harrison, David J., Overton, Ian M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483837/ https://www.ncbi.nlm.nih.gov/pubmed/28648142 http://dx.doi.org/10.1186/s12916-017-0874-9

Ejemplares similares

Differential Expression of Prognostic Proteomic Markers in Primary Tumour, Venous Tumour Thrombus and Metastatic Renal Cell Cancer Tissue and Correlation with Patient Outcome
por: Laird, Alexander, et al.
Publicado: (2013)

Carbonic Anhydrase 9 Expression Increases with Vascular Endothelial Growth Factor–Targeted Therapy and Is Predictive of Outcome in Metastatic Clear Cell Renal Cancer
por: Stewart, Grant D., et al.
Publicado: (2014)

Dynamic epigenetic changes to VHL occur with sunitinib in metastatic clear cell renal cancer
por: Stewart, Grant D., et al.
Publicado: (2016)

Multidimensional intratumour heterogeneity in neuroblastoma
por: von Stedingk, Kristoffer, et al.
Publicado: (2019)

TMA Navigator: network inference, patient stratification and survival analysis with tissue microarray data
por: Lubbock, Alexander L. R., et al.
Publicado: (2013)

Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification
por: Dunne, Philip D., et al.
Publicado: (2017)

A transcriptomic intratumour heterogeneity-free signature overcomes sampling bias in prognostic risk classification for hepatocellular carcinoma
por: Luo, Shangyi, et al.
Publicado: (2023)

The Use of Automated Quantitative Analysis to Evaluate Epithelial-to-Mesenchymal Transition Associated Proteins in Clear Cell Renal Cell Carcinoma
por: O'Mahony, Fiach C., et al.
Publicado: (2012)

Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives
por: Saunders, Nicholas A, et al.
Publicado: (2012)

Risk Stratification in Cost-Effectiveness Analyses of Cancer Screening: Intervention Eligibility, Strategy Choice, and Optimality
por: O’Mahony, James F.
Publicado: (2021)

Breast Carcinoma, Intratumour Heterogeneity and Histological Grading, Using Geostatistics
por: Sharifi‐Salamatian, Vénus, et al.
Publicado: (2000)

popFBA: tackling intratumour heterogeneity with Flux Balance Analysis
por: Damiani, Chiara, et al.
Publicado: (2017)

Intratumour heterogeneity in microRNAs expression regulates glioblastoma metabolism
por: Alfardus, Huda, et al.
Publicado: (2021)

The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinoma
por: Evan, Theodore, et al.
Publicado: (2022)

Reproducibility of (18)F-fluoromisonidazole intratumour distribution in non-small cell lung cancer
por: Grkovski, Milan, et al.
Publicado: (2016)

The Efficacy of Sunitinib Treatment of Renal Cancer Cells Is Associated with the Protein PHAX In Vitro
por: Al-Lamki, Rafia S., et al.
Publicado: (2020)

Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma
por: Nguyen, Phuong H. D., et al.
Publicado: (2021)

Intratumour heterogeneity in the uptake of macromolecular therapeutic agents in human melanoma xenografts
por: Graff, B A, et al.
Publicado: (2003)

Plasticity and intratumoural heterogeneity of cell surface antigen expression in breast cancer
por: Remšík, Ján, et al.
Publicado: (2018)

Immunophenotypic features of dedifferentiated skull base chordoma: An insight into the intratumoural heterogeneity
por: Batista, Kelvin Manuel Piña, et al.
Publicado: (2017)

Intratumoural Heterogeneity Underlies Distinct Therapy Responses and Treatment Resistance in Glioblastoma
por: Akgül, Seçkin, et al.
Publicado: (2019)

Limited impact of intratumour heterogeneity on molecular risk assignment in endometrial cancer
por: van Esterik, Manouk, et al.
Publicado: (2017)

Microbench: automated metadata management for systems biology benchmarking and reproducibility in Python
por: Lubbock, Alexander L R, et al.
Publicado: (2022)

Microsatellite instability and intratumoural heterogeneity in 100 right-sided sporadic colon carcinomas
por: Chapusot, C, et al.
Publicado: (2002)

Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity
por: Hoefflin, Rouven, et al.
Publicado: (2016)

Study on the Value of DCE-MRI in Differentiating Glossitis and Tongue Cancer and the Intratumour Heterogeneity
por: Liu, Fenghai, et al.
Publicado: (2021)

MYTH: An algorithm to score intratumour heterogeneity based on alterations of DNA methylation profiles
por: Liu, Qian, et al.
Publicado: (2021)

Single-cell transcriptome profiling reveals intratumoural heterogeneity and malignant progression in retinoblastoma
por: Yang, Jie, et al.
Publicado: (2021)

Intratumour microbiome of pancreatic cancer
por: Guan, Shi-Wei, et al.
Publicado: (2023)

Author Correction: Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma
por: Nguyen, Phuong H. D., et al.
Publicado: (2021)

Inter and Intratumour Heterogeneity: A Barrier to Individualized Medical Therapy in Renal Cell Carcinoma?
por: Fisher, Rosalie, et al.
Publicado: (2012)

Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence
por: Ellis, Hayley P., et al.
Publicado: (2015)

Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer
por: von Loga, Katharina, et al.
Publicado: (2020)

Leveraging single‐cell sequencing to unravel intratumour heterogeneity and tumour evolution in human cancers
por: Bowes, Amy L, et al.
Publicado: (2022)

Epigenetically regulated lncRNAs dissect the intratumoural heterogeneity and facilitate immune evasion of glioblastomas
por: Xu, Dahua, et al.
Publicado: (2023)

Systematic Evaluation of the Prognostic Impact and Intratumour Heterogeneity of Clear Cell Renal Cell Carcinoma Biomarkers
por: Gulati, Sakshi, et al.
Publicado: (2014)

Radiogenomic signatures reveal multiscale intratumour heterogeneity associated with biological functions and survival in breast cancer
por: Fan, Ming, et al.
Publicado: (2020)

Reproducibility of 18F-fluoromisonidazole intratumour distribution in non-small cell lung cancer; methodological issues to avoid mismanagement of the patients
por: Sabour, Siamak
Publicado: (2017)

Author Correction: Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer
por: von Loga, Katharina, et al.
Publicado: (2020)

Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions
por: Schmelz, Karin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uvqhm30h2c4qffm2q2bntiuvv2